No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Matinas BioPharma Files to Sell 16.9M Shares of Common Stock for Holders
Matinas BioPharma | 10-K: FY2024 Annual Report
Matinas Biopharma Delays 10-K Filing
Express News | Matinas BioPharma Holdings Inc - Eric Ende Resigns as Chairman of Matinas BioPharma
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
Matinas Biopharma Holdings Shares Are Trading Higher After the Company Announced It Entered Into a Deal for the Acquisition of Certain Preferred Stock.